Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) Director Blake Borgeson sold 8,885 shares of the business’s stock in a transaction that occurred on Tuesday, June 27th. The shares were sold at an average price of $7.39, for a total transaction of $65,660.15. Following the completion of the sale, the director now owns 7,528,989 shares of […]
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Rating) Director Blake Borgeson sold 15,485 shares of the firm’s stock in a transaction on Tuesday, June 13th. The stock was sold at an average price of $9.98, for a total transaction of $154,540.30. Following the completion of the sale, the director now owns 7,525,262 shares in the company, […]
Morgan Stanley assumed coverage on shares of Recursion Pharmaceuticals (NASDAQ:RXRX – Get Rating) in a report issued on Monday morning, The Fly reports. The brokerage issued an equal weight rating and a $8.00 target price on the stock. A number of other equities research analysts have also weighed in on RXRX. Needham & Company LLC […]